tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JOINN Laboratories to Review Third Quarter Results

Story Highlights
JOINN Laboratories to Review Third Quarter Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) just unveiled an update.

JOINN Laboratories (China) Co., Ltd. has announced that its board of directors will meet on 30 October 2025 to consider and approve the company’s third quarterly results for the nine months ending 30 September 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (HK:6127) stock is a Hold with a HK$14.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.

More about JOINN Laboratories (China) Co., Ltd. Class H

JOINN Laboratories (China) Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the research and development sector. The company is involved in providing laboratory services and solutions, focusing on scientific research and innovation.

Average Trading Volume: 7,465,862

Technical Sentiment Signal: Buy

Current Market Cap: HK$25.11B

See more insights into 6127 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1